Evidence map›Paper›PMID 36836738›Full record

ReviewLife (Basel, Switzerland)2023

Anticancer Therapy and Mortality of Adult Patients with Hematologic Malignancy and COVID-19: A Systematic Review and Meta-Analysis.

Wen-Li Lin, Thi-Hoang-Yen Nguyen, Li-Min Wu, Wen-Tsung Huang, Shih-Bin Su

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Life (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Wen-Li LinCenter for Quality Management, Chi Mei Medical Center, Liouying, Tainan 71004, Taiwan.
Thi-Hoang-Yen NguyenDepartment of Environmental and Occupational Health, National Cheng Kung University, Tainan 704302, Taiwan.
Li-Min WuSchool of Nursing, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.ORCID 0000-0002-0184-9116
Wen-Tsung HuangDivision of Hematology and Oncology, Department of Internal Medicine, Chi Mei Medical Center, Liouying, Tainan 71004, Taiwan.
Shih-Bin SuDepartment of Occupational Medicine, Chi Mei Medical Center, Tainan 71004, Taiwan.

Funding

Chi Mei Medical Center CLFHR 10940 and 110CM-KMU-03
6 · The paper itself

Abstract

Coronavirus disease 2019 (COVID-19) might affect cancer treatment outcomes. This systematic review and meta-analysis identified the prognostic predictors of adult patients with hematologic malignancies and COVID-19, and evaluated the effect of anticancer therapy on mortality. We performed a literature search of electronic databases and identified additional studies from the bibliographies of the articles that were retrieved. Two investigators independently extracted data according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) reporting guidelines. We evaluated study quality using the Newcastle-Ottawa Scale and performed a meta-analyses in order to evaluate the effect of anticancer therapy on mortality among adult patients with hematologic malignancies and COVID-19. Heterogeneity was assessed with the

Indexed as

anticancer therapyCOVID-19hematologic malignancymeta-analysismortalitysystematic review

Identifiers

PMID36836738
PMCPMC9967921

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.